Arm Holdings plc - American Depositary Shares (ARM)

243.32
-7.40 (-2.95%)
NASDAQ· Last Trade: Aug 21st, 7:01 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Why BitMine Immersion Technologies Stock Skyrocketed by 26% This Weekfool.com
Generally speaking, as cryptos go, so goes the company's equity.
Via The Motley Fool · August 21, 2026
Advanced Micro Devices vs. Arm Holdings: Comparing Revenue Trends Between These Artificial Intelligence Companiesfool.com
Via The Motley Fool · August 21, 2026
Prediction: Nvidia Stock Will Go Parabolic After Aug. 26. Here Are 2.3 Trillion Reasons Whyfool.com
The huge revenue backlogs of major U.S. hyperscalers could help Nvidia crush expectations when it releases its quarterly results.
Via The Motley Fool · August 21, 2026
The History of Indian Bronze Sculpturestalkmarkets.com
Bronze sculpture is one of India's oldest and most beautiful art forms. For thousands of years, Indian artists have used bronze to create images of gods, g
Via Talk Markets · August 21, 2026
ARM Holdings (NASDAQ:ARM) Shows Strong Growth and a Technical Breakout Setupchartmill.com
Via Chartmill · August 14, 2026
Pantograph Charger Market: A Deep Dive into Regional Trendstalkmarkets.com
Electric buses don't have time to sit around waiting for a slow charge — and that's exactly the problem pantograph chargers were built to solve. By droppin
Via Talk Markets · August 20, 2026
How to Prevent Sports Injuries During Exercisetalkmarkets.com
Exercise is one of the best ways to improve strength, flexibility, endurance, and overall health. Whether you enjoy running, weight training, cycling, swim
Via Talk Markets · August 20, 2026
What Makes a Reliable Rear Windshield Wiper for KIA Vehicles?talkmarkets.com
Quick Q&AQ: What makes a rear windshield wiper reliable for KIA vehicles?A: A reliable rear wiper for KIA models comes down to accurate model-specific fitm
Via Talk Markets · August 20, 2026
Allogene (ALLO) Q2 2026 Earnings Call Transcriptfool.com
Cema-cel hit 58.3% MRD negativity in ALPHA3 with zero treatment hospitalizations.
Via The Motley Fool · August 19, 2026
How Morgan Stanley Turned the SpaceX IPO Into a Money Machinetalkmarkets.com
When a company like SpaceX goes public, most people think about the headline event: a huge valuation, a stock ticker etc., what doesn't get talked about as
Via Talk Markets · August 19, 2026
Why Chassis Parts Are Becoming a Strategic Category in the Global Automotive Aftermarkettalkmarkets.com
The automotive aftermarket is often viewed through the most visible categories: engine components, brake systems, batteries, tires, and routine maintenance
Via Talk Markets · August 19, 2026
Stoke Therapeutics’ Dravet Trial Tops Enrollment Target With Zero Dropoutsmarketbeat.com
Stoke Therapeutics (NASDAQ:STOK) said its Phase III EMPEROR study of zorevunersen for Dravet syndrome has enrolled 162 patients, exceeding its target enrollment of 150, with no patient discontinuations reported to date. Speaking at a Canaccord Genuity event, Chief Executive Officer Ian Smith said t
Via MarketBeat · August 17, 2026
EyePoint’s DURAVYU Misses Primary Endpoint in Phase III Wet AMD Trialmarketbeat.com
Eyepoint Pharmaceuticals (NASDAQ:EYPT) reported topline results from LUGANO, the first of two Phase III trials evaluating DURAVYU, a vorolanib intravitreal insert, in patients with wet age-related macular degeneration, or wet AMD. The study did not meet its primary non-inferiority endpoint in the fu
Via MarketBeat · August 17, 2026
argenx VYVGART Hits Phase III Goal in Autoimmune Myositis, Eyes IMNM Filingmarketbeat.com
argenx (NASDAQ:ARGX) reported positive top-line results from its Phase III ALKIVIA trial of VYVGART Hytrulo in autoimmune myositis, meeting its primary endpoint in a combined population of patients with immune-mediated necrotizing myopathy, or IMNM, and dermatomyositis, or DM. The study evaluated e
Via MarketBeat · August 17, 2026
RTX, Pentagon Sign $23 Billion Tomahawk Missile Contractinvestors.com
The Department of Defense has been pushing contractors to ramp up production of critical munitions. RTX stock rose about 1% on Monday.
Via Investor's Business Daily · August 17, 2026
Restore Spine and Pain Center : Cervical Radiculopathy Specialists Holly Springstalkmarkets.com
Neck pain accompanied by arm discomfort, numbness, tingling, or weakness can sometimes be associated with irritation or compression of a cervical spinal ne
Via Talk Markets · August 17, 2026
IonQ Paid $1.8 Billion for a Chip Foundry. Here's What Investors Should Know.fool.com
The quantum computing specialist now owns a chip factory that generates nearly twice its own revenue.
Via The Motley Fool · August 16, 2026
How Specialists Perform Carotid Artery Stenting in Sector 43 Gurugramtalkmarkets.com
A sudden bout of dizziness. A brief moment where an arm feels weak, then feels fine again a few minutes later. Easy to dismiss, easy to explain away and so
Via Talk Markets · August 14, 2026
Here’s a Dirt-Cheap Canadian Dividend Stock I’d Hold for Yearshttps://www.fool.ca/2026/08/13/heres-a-dirt-cheap-canadian-dividend-stock-id-hold-for-years/?source=iedfctemc0000001&utm_source=financialcontent&utm_campaign=CA_All_Articles&utm_content=Articles&utm_medium=rssfeed&lidx=0&referring_guid=d7abb4d8-6332-426e-a037-b1a1b7dc9d22
Let's have a look at one dirt-cheap Canadian dividend stock that seemingly got left behind as some of the nation's best income stars rose smoothly in this great TSX bull run.
Via The Motley Fool · August 13, 2026
Lineage Cell Therapeutics (LCTX) Q2 2026 Earnings Call Transcriptfool.com
CEO outlines manufacturing scale-up strategy for cell therapies amid $50.8M cash runway.
Via The Motley Fool · August 13, 2026
Asian Market Circuit Breakers Hit Stocks, Not AI Demandmarketbeat.com
Asian market halts and currency-driven sell-offs can drag down NVIDIA, Micron, Advantest, Arm, and IBM despite steady AI and semiconductor demand, creating potential valuation opportunities.
Via MarketBeat · August 13, 2026
Why Arm Holdings Stock Popped Todayfool.com
Arm stock could be the biggest beneficiary of a shift to CPU sales for AI.
Via The Motley Fool · August 13, 2026
Intellia (NTLA) Q2 2026 Earnings Call Transcriptfool.com
Lonvo-z Phase III trial met primary endpoint with 87% attack reduction versus placebo.
Via The Motley Fool · August 13, 2026
Analysts Are Undervaluing Berkshire Hathaway Now That Greg Abel Is Putting the Company's Cash to Work. But That's Not the Reason.fool.com
The most encouraging aspect of the conglomerate's second-quarter report appears to have gone mostly overlooked.
Via The Motley Fool · August 13, 2026
Google Parent Alphabet Just Revealed How Many SpaceX Shares It Owns... and the Figure Is a Doozyfool.com
Alphabet has turned into the Warren Buffett of Wall Street.
Via The Motley Fool · August 13, 2026